France· FR:63609769
MOMETASONE SANDOZ 50 microgrammes/dose, suspension pour pulvérisation nasale
A medicinal product containing furoate de mométasone monohydraté, registered in France by SANDOZ, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- FUROATE DE MOMÉTASONE MONOHYDRATÉ
- Manufacturer
- SANDOZ
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009275056761 flacon(s) polyéthylène haute densité (PEHD) de 17 g avec pompe(s) doseuse(s) polypropylène polyéthylèneEUR 4.46
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Furoate de mométasone monohydraté in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAsmanex 200micrograms/dose TwisthalerWaymade Healthcare Plc
- United StatesallergyCVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED
- PolandAleric SprayUS Pharmacia Sp. z o.o.
- GermanyAllergo-MomelindDoppelherz Pharma Gmbh
- CzechiaASMANEXN.V. Organon, Oss
- SpainASMANEX TWISTHALER 200 microgramos POLVO PARA INHALACIONOrganon Salud S.L.
- SwedenAphiahsone 50 mikrogram/dos Nässpray, suspensionGlenmark Arzneimittel GmbH
- NetherlandsBemrist Breezhaler 125 microgram/127,5 microgram inhalatiepoeder in harde capsulesNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Asmanex Twisthaler, Elocon
- Belgium · Asmanex Twisthaler, Elocom
- Bulgaria · Блоктимо, Елоком
- Cyprus · Elocon, Movesan
- Czechia · Asmanex, Elocom
- Germany · Allergo-Momelind, Asmanex Twisthaler
- Denmark · Aphiahsone, Asmanex Twisthaler
- Estonia · Breso, Elocon
- Spain · Asmanex Twisthaler, Elocom
- Finland · Asmanex Twisthaler, Demoson
- United Kingdom (Northern Ireland) · Asmanex Twisthaler, Clarinaze Allergy Control
- Greece · Asmanex Twisthaler, Elocon
- Croatia · Elocom, Momanose
- Hungary · Azocutan, Elocom
- Ireland · Asmanex Twisthaler, Elocon
- Iceland · Elocon, Kalmente
- Italy · Arinit, Asmanex
- Lithuania · Breso, Elocon
- Luxembourg · Elocom, Monovo
- Latvia · Breso, Elocon
- Malta · Elocon, Nasonex
- Netherlands · Elocon, Elocon Vet
- Norway · Asmanex Twisthaler, Elocon
- Poland · Aleric Spray, Edelan
- Portugal · Asmanex Twisthaler, Desdek
- Romania · Elocom, Furoat De Mometazonă Cipla
- Sweden · Aphiahsone, Asmanex Twisthaler
- Slovenia · Asmanex Twisthaler, Elocom
- Slovakia · Asmanex, Elocom
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b200a67c-6256-462b-9975-4587d6660950 GET /v1/drugs/b200a67c-6256-462b-9975-4587d6660950?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63609769",
"date_amm": "2014-01-02",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "FUROATE DE MOMÉTASONE MONOHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "suspension pour pulvérisation",
"voies_administration": "nasale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about furoate de mométasone monohydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.